Introduction. The current study aimed to assess profiles of peptide YY and ghrelin, visual analog scales (VAS) for hunger and satiety, and ad libitum intake in obese and non-obese women.
INTRODUCTION
Obesity is a major health problem globally, including in Indonesia. According to the Basic Health Research (Riskesdas) in 2013, the prevalence of obesity based on body mass index (BMI) in Indonesian women above 18 years old was 32.9% [1] . Combination of various risk factors can increase the incidence of obesity, including high calories intake, fat intake, and low physical activity [2] . From a cohort of obese patients who had a diet and lose their weight initially, only 25% will have a sustained weight loss [3] . Hunger and satiety signals were regulated by the hypothalamus and were integrated with the signal of the brain stem [4, 5] .
Gastrointestinal tract produces numerous neuropeptides, such as peptide YY, an anorexigenic gut hormone, and ghrelin, an orexigenic gut hormone [6, 7] . Peptide YY is secreted because of the presence of foods in the gut lumen and suppressed appetite [8] . Before a meal, the peptide YY level was low, however, 15 minutes after food enters the mouth, the peptide YY level will increase and reach its peak in 60 minutes after the meal [9] . All macronutrients, mostly fat, will influence the release of peptide YY [10] . Ghrelin is mainly secreted by endocrine cells of the stomach between meals when the stomach is empty and is also secreted during fasting [11] . Studies showed that ghrelin works in cells of the pancreas, hypothalamus, pituitary and a variety of peripheral tissues [12] .
Visual analog scale (VAS) is a measurement of subjective sensations of human to have an eating desire or not [13] . As a consistent assessment tool, VAS can describe energy intake and is not influenced by the earlier diet [14] [15] [16] . The aim of our study is to assess profiles of peptide YY, ghrelin, VAS for hunger, VAS for satiety, and ad libitum intake in obese and non-obese Indonesian women.
MATERIAL AND METHODS

DESIGN, SETTING, AND SUBJECTS
This open-label non-randomized interventional study had an approval from the Ethics Committee in Faculty of Medicine, Universitas Indonesia. The subjects were invited by the Department of Nutrition, Faculty of Medicine Universitas Indonesia. The inclusion criteria were women aged 20-40 years with body mass index (BMI) 18.5-23 kg/m 2 for non-obese group and 25-30 kg/m 2 for obese group, able to drink milk, had a stable body weight in the last 6 months (change in body weight of 4 kg or less) and had normal blood glucose level. The exclusion criteria were subjects who never had breakfast, were doing a weight loss program, under medications or drugs of fat absorption inhibitor or hunger suppressant, had a history of gastrointestinal resection, were pregnant, were breastfeeding and were refused to sign the informed consent. Subjects who are willing to participate in this study were asked to sign an approval sheet and those who did not complete all research stages would be dropped out.
Before the study started, the subjects should get balanced composition diet in a 3 days period. One day before the study started, they had a fasting period from 10 pm to 8 am and attended in the morning to follow the stages of the study. During the fasting period, the subjects were free to consume water, but they were not allowed to drink in 2 hours before breakfast. Then, the subjects were given a breakfast with balanced macronutrient composition (12.4% protein, 68.2% carbohydrate, and 22.6% fat of energy) in the form of liquid foods or milk material and had the same taste. The total calorie needs were calculated by appropriate calculation of subjects energy needs. Subjects should eat the breakfast within 15 minutes. In that period, they were allowed to consume as much as 600 mL of water within 4 hours.
ASSESSMENT OF OUTCOMES
Peptide YY and ghrelin analysis and VAS measurements for hunger and satiety were performed during fasting period and 15, 60, 120, and 180 minutes after breakfast. The ad libitum intakes were compared in 4 hours after breakfast. Peptide YY and ghrelin were determined in accordance with the factory protocols. Peptide YY were analyzed by radioimmunoassay (RIA) of PYY 3-36 fragments using Human PYY 3-36 specific RIA Kit (MilliporeMerck KGaA, Darmstadt, Germany). Ghrelin was determined by using Human Active Ghrelin Elisa Kit (Millipore-Merck KGaA). Hunger and satiety were measured using a visual analog scale (VAS) with 100 mm straight lines, consisting of extreme choices on the two end lines. Subjects choose between the two end lines by giving "X" sign. The flow of study is described in Figure 1 . 
STATISTICAL ANALYSIS
The analysis of peptide YY level, ghrelin level, VAS for hunger and satiety between obese and non-obese groups were presented in graphs and area under the curve (AUC). AUC was calculated using the AutoCAD software program (San Rafael, CA, USA). The non paired t test was used to analyze between obese and non-obese groups for normally distributed numerical data of peptide YY, ghrelin, VAS for hunger and satiety. Meanwhile, Mann-Whitney test was used for abnormally distributed data. Statistical analyses were performed using Statistical Package for the Social Science (SPSS) software version 19.0 for Windows (Chicago, IL, USA) and P-value < 0.5 was considered to be statistically significant.
RESULTS
There were 18 people in the obese group and 22 people in the non-obese group which followed this study. There were no significant differences (p > 0.05) in terms of age, educational level, and physical activity between both groups. As expected, BMI and nutritional status had a significant difference (p < 0.05). These results were described in Table 1 .
First, we examined the Peptide YY and ghrelin in obese and non-obese groups. Both peptide YY level in obese and non-obese group were increased, started at 15 minutes, steadily in the 60 and 120 minutes, and finally reached its peak at 180 minutes after breakfast. The levels of peptide YY during fasting and post-prandial in 15, 60, 120, 180 minutes in the obese group were lower than in the non-obese group (Figure 2) . In 15 and 60 minutes after breakfast, the levels of ghrelin in both obese and non-obese groups were declined, compared to the fasting period. Then, it was increased in 120 and 180 minutes after breakfast. Levels of ghrelin during fasting and 15, 120, and 180 minutes after breakfast in obese group were lower than in non-obese group ( Figure 3) .
Next, we analyzed the degree of hunger and satiety by VAS measurements. VAS for hunger in both groups showed the decreased hunger in 15 minutes after breakfast followed by increased hunger in 60 and 120 minutes and reached the peak in 180 minutes after breakfast as seen in Figure 4 . VAS for hunger in obese group during fasting and in 15 minutes after breakfast were lower than in nonobese group. However, in 60, 120, and 180 minutes after breakfast, VAS for hunger in obese group was higher than in non-obese group. As described in Figure 5 , VAS for satiety in obese and non-obese group were increased and reached the peak in 15 minutes, but they were declined in 60 to 180 minutes. VAS for satiety during fasting period in obese group was higher than in non-obese group while VAS during post-prandial in 15, 60, and 180 minutes was lower in the obese group, compared to the non-obese group. We then determined the area under the curve (AUC) of Peptide YY, Ghrelin, and VAS for hunger and satiety. The AUC of peptide YY in the obese group was significantly lower than in the non-obese group (p < 0.05). There were no significant differences in AUC of ghrelin, VAS for hunger and satiety in both obese and non-obese group (Table 2) .
Finally, we investigated the ad libitum intake in obese and non-obese groups during the lunch period (4 hours after breakfast). We found that total energy, protein, and fat intake in obese group were significantly higher than in non-obese group (p = 0.01), meanwhile, there was no significant difference in carbohydrate intake (p = 0.211), as detailed in Table 3 .
DISCUSSION
Altered gut hormones in the obese individuals remain to be elucidated. This study showed that the level of anorexigenic gut hormone peptide YY during fasting and post-prandial period in the obese group was lower than in the non-obese group. AUC was also significantly different between both groups. Low peptide YY AUC reflects the high willingness 20 for a meal during fasting and during 15, 60, 120, 180 minutes post-prandial among obese subjects. These findings suggest that obesity is not only associated with leptin resistance condition [17] . Low level of peptide YY in the obese group resulted in high VAS for hunger and low VAS for satiety. In one study, when the normal and obese subjects are given a physiological intravenous dose of peptide YY, their intake would be declined more than 30% within 2 hours after the infusion [17] .
Although ghrelin is an orexigenic gut hormone, however the level of ghrelin in obese subjects was low in this study and in some previous studies [18, 19] . These results suggest an inverse relationship between BMI, composition, and distribution of visceral fat and fasting or post-prandial ghrelin level. This finding also highlighted the adaptation mechanism in which obese subjects will not gain weight and normal subjects will not lose weight. The regulation disrupted the cholinergic vagus nerve which against decreasing post-prandial ghrelin levels was also found in obese subjects [20] .
Insulin resistance which causes hyperinsulinemia generally occurred in obese subjects. Insulin is known to inhibit the signal which secretes ghrelin [21] . Obese subjects have a reduced ghrelin secretion before and after meals. In one trial of low-dose infusion of ghrelin, it was shown that obese subjects have an increase in ad libitum energy intake, whereas normal subjects have not an increasing intake [22] . The study suggests that obese subjects have high sensitivity against the ghrelin effect in increasing hunger, in spite of the low levels of ghrelin circulation. In thin subjects, however, they have higher levels of ghrelin during fasting period and prominent declining levels of ghrelin after meals. Thin subjects have a greater hunger before meals, but have a faster satiety after meals.
Hunger and satiety were measured by VAS. In obese subjects, VAS for hunger during fasting period was lower and VAS for hunger during postprandial period was higher than in non-obese subjects. VAS for satiety during fasting period in obese subjects was higher and VAS for satiety during post-prandial period was lower than in nonobese subjects. The results of hunger and satiety with VAS measurements were consistent in this study. This was also shown in AUC, VAS for hunger and satiety in obese subjects has tended to be lower than in non-obese subjects, although it did not reach the statistically significant threshold. Taken together, these findings confirmed the power of repetition, the strength of the research, and the validity of the VAS to assess hunger and satiety [14, 15] .
The ad libitum lunch intake analysis revealed that obese subjects have higher intake than nonobese, especially in fat intake, but not in carbohydrate. Satiety was assessed calculating the ad libitum food calorie intake after 4 hours from breakfast. That method was the high reproducibility in food intake assessment and was not affected by food intake one day earlier [23] . The high intake in obese subjects was consistent with the level of VAS for hunger and satiety.
Based on the results of gut hormone profile, VAS for hunger, VAS for satiety, and ad libitum intake, we suggest that anorexigenic gut hormone has a tendency of inverse relationship with VAS for satiety. Ad libitum intake analysis in obese subjects was appropriate with higher VAS for hunger and lower VAS for satiety. It was also appropriate with the level of peptide YY, but not in the level of ghrelin.
CONCLUSION
The current study highlighted the roles of peptide YY and ghrelin in the regulation of hunger and satiety in obese women. To the best of our knowledge, our study is the first to reveal lower level of peptide YY, ghrelin and satiety, and a higher level of hunger and ad libitum intake 4 hours after breakfast in obese Indonesian women, as compared to non-obese women. In the future treatment of obesity, peptide YY may be considered as a potential treatment to suppress hunger. 
